Follow

, i.e. persistent symptoms and reduced despite normal concentration, affects 10% of patients on . Careful, multimodal and personalised treatment can result in significantly improved outcomes.

doi.org/10.1007/978-981-96-368

Sign in to participate in the conversation
Qoto Mastodon

QOTO: Question Others to Teach Ourselves
An inclusive, Academic Freedom, instance
All cultures welcome.
Hate speech and harassment strictly forbidden.